Q4 2013 13F Holders as of 12/31/2013
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
72.2M
-
Number of holders
-
227
-
Total shares
-
62.9M
-
Shares change
-
+19.5K
-
Total reported value, excl. options
-
$3.09B
-
Value change
-
+$884K
-
Put/Call ratio
-
1.7
-
Number of buys
-
5
-
Number of sells
-
-2
-
Price
-
$49.06
Significant Holders of WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) as of Q4 2013
231 filings reported holding WST - WEST PHARMACEUTICAL SERVICES INC - Common Stock as of Q4 2013.
WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) has 227 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 62.9M shares
of 72.2M outstanding shares and own 87.13% of the company stock.
Largest 10 shareholders include Neuberger Berman Group LLC (5.44M shares), VANGUARD GROUP INC (5.4M shares), FRANKLIN RESOURCES INC (4.48M shares), BlackRock Fund Advisors (3.83M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.99M shares), KALMAR INVESTMENTS INC /DE/ (1.98M shares), BAMCO INC /NY/ (1.82M shares), BlackRock Institutional Trust Company, N.A. (1.82M shares), GRANAHAN INVESTMENT MANAGEMENT INC/MA (1.67M shares), and State Street Corp (1.58M shares).
This table shows the top 227 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.